The Cabinet of Ministers has authorized the sale of over-the-counter drugs at gas stations, provided that the appropriate license is obtained, according to Health Minister Viktor Lyashko.
“We have authorized the sale of over-the-counter drugs at gas stations, provided that the appropriate license is obtained. This applies to situations where there are no pharmacies nearby: in villages, in frontline communities, or late at night outside of large cities. We are only talking about safe, over-the-counter drugs that people use on their own. In wartime, this is especially important, as gas station chains often remain operational even during power outages. The requirements for sales at gas stations ensure the quality and safety of medicines. This will help lower prices and make medicines more affordable,” he wrote on Facebook.
According to him, the government has also made a number of decisions, in particular, pharmacies in state and municipal hospitals are required to sell only the three lowest-priced drugs from the National Catalog among drugs with the same composition and effect.
In addition, specialists with a broader range of qualifications, as defined by law, can now be employed in pharmacies and pharmacy outlets.
“In rural areas and frontline communities, medicines can be dispensed in pharmacies (without manufacturing) by specialists with at least a junior bachelor’s degree in nursing and a certificate in pharmacy (retail sale of medicines). This allows pharmacies to build more effective teams, especially in communities with staff shortages, while ensuring the quality and safety of pharmaceutical care for patients,” Lyashko wrote.
In addition, the government has regulated the rules for providing marketing services in the pharmaceutical sector.
“This refers to transparent tools for promoting drugs at points of sale: providing information, placing materials, or participating in loyalty programs. The launch of the National Price Catalog makes it impossible to use marketing as a tool for covertly increasing the cost of drugs—the declared prices are fixed, and promotion becomes a mechanism for informing and increasing accessibility for patients,” the minister noted.